[AVTE] YoY Quarter Result on 30-Sep-2022 [#Q3]

Stock
[AVTE] Aerovate Therapeutics, Inc.
Announcement Date
14-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -10.68%
YoY- -110.61%
Quarter Report
AVTE's Result
AVTE's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 CAGR
Revenue 0 0 0 0 -
PBT -19,563 -13,588 -6,184 -2,307 103.92%
Tax -25 -564 0 0 -
NP -19,563 -13,024 -6,184 -2,307 103.92%
Tax Rate - - - - -
Total Cost 19,563 13,024 6,184 2,307 103.92%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 CAGR
NP Margin 0.00 0.00 0.00 0.00 -
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 CAGR
EPS -0.71 -0.53 -0.26 -9.49 -57.86%
EPS Diluted -0.71 -0.53 -0.26 -9.49 -57.86%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.